Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subdermal levonorgestrel implants. Three years' experience in Cairo, Egypt

D E Rizk1

  • 1Department of Obstetrics and Gynaecology, Llandough Hospital, Cardiff, Wales.

The Journal of Reproductive Medicine
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing confidence and competence of senior medical students in an obstetrics and gynaecology clerkship using an OSCE.

Education for health (Abingdon, England)·2004
Same author

Knowledge and practice of contraception in United Arab Emirates women.

The journal of family planning and reproductive health care·2002
Same author

Measurement-specific quality-of-life satisfaction during the menopause in an Arabian Gulf country.

Climacteric : the journal of the International Menopause Society·2002
Same author

Abnormal vascular coiling of the umbilical cord in gestational diabetes mellitus.

Archives of physiology and biochemistry·2002
Same author

Epidemiology consequences and natural history of urinary incontinence in non-caucasian women.

International urogynecology journal and pelvic floor dysfunction·2002
Same author

The prevalence and determinants of health care-seeking behavior for fecal incontinence in multiparous United Arab Emirates females.

Diseases of the colon and rectum·2001

The subdermal levonorgestrel implant (SLI) is a safe and effective contraceptive. This study shows a low pregnancy rate over three years, with menstrual changes being the main side effect.

Area of Science:

  • Reproductive Health
  • Contraception
  • Endocrinology

Background:

  • Long-acting reversible contraceptives (LARCs) are crucial for family planning.
  • Subdermal levonorgestrel implant (SLI) offers a low-dose, progestin-only LARC option.

Purpose of the Study:

  • To evaluate the efficacy, safety, and acceptability of the subdermal levonorgestrel implant (SLI).
  • To assess the SLI as a novel, long-acting, low-dose, progestin-only contraceptive method for women.

Main Methods:

  • Prospective, observational study.
  • Advanced phase III clinical trial conducted in a family planning clinic.
  • Follow-up of 350 women over three years.

Main Results:

  • A net three-year cumulative pregnancy rate of 0.98% was observed.

Related Experiment Videos

  • Menstrual disturbances (amenorrhea, menorrhagia) were the primary side effects, affecting 25% in the third year.
  • Continuation rate after three years was 65.5%, with removals mainly due to menstrual issues or other medical/insertion site complications.

    • Conclusions:

    • The subdermal levonorgestrel implant demonstrates high efficacy and safety.
    • The SLI is an acceptable contraceptive option with a favorable safety profile.
    • The implant represents a valuable addition to available contraceptive methods.